Dr Sukant Khurana | Founder and CEO, Ioncure Tech Pvt Ltd

Dr Sukant Khurana | Founder and CEO, Ioncure Tech Pvt Ltd

  • Dr Khurana is the Founder and CEO of Ioncure Tech Private Limited.
  • He is a researcher in the fields of artificial intelligence and epilepsy.

Podcast

Overview

Epilepsy, a global challenge, has stumped healthcare professionals with its diverse nature. Enter the visionary realm of AI, its potential in epilepsy care is revolutionary. Dr Sukant Khurana, CEO of Ioncure Tech, pioneers AI’s role in redefining epilepsy diagnosis and treatment. Join us as we explore the intricate relationship between AI and epilepsy, where innovation meets compassion, offering hope to those with neurological complexities. 

[00:30] – About Dr Sukant Khurana

  • Dr Khurana is the Founder and CEO of Ioncure Tech Private Limited.
  • He is a researcher in the fields of artificial intelligence and epilepsy.
  • He has been recognised for his work in data privacy and ethics in the United States. 

[00:57] – Tell me about the work you are doing at Ioncure Tech. What got you interested in the intersection of AI and epilepsy?

  • Ioncure Tech Pvt Ltd is described as a 360-degree epilepsy company.
  • We are involved in various aspects, including drug discovery, genomics, brain surgery, brain stimulation, epilepsy alarm systems, and electronic records maintenance.
  • We are also involved in aspects related to social issues like dating and matchmaking for individuals with epilepsy.

[06:34] – Are there any potential risks associated with relying on AI for epilepsy treatment or prediction?

  • It is important to consider population differences in data used for AI, especially in genetics. 
  • AI is as good as the data set it is trained on.
  • There are potential ethical concerns related to profit-driven motives in healthcare.

[18:34] – How do you envision the future of AI in epilepsy diagnosis and treatment?

  • AI will completely transform epilepsy care. 
  • There are going to be breakthrough advancements in diagnostics, prevention, and management of cognitive and emotional challenges. 
  • There is also a possibility of personalized therapeutics based on genetic factors.

RESOURCES:

Learn more about Dr Sukant Khurana: LinkedIn 

Enjoyed this podcast?

If you learned new insights about the intersection of AI and epilepsy care, subscribe and share them with friends! 

Love to give us 5 stars? ⭐⭐⭐⭐⭐ If you do, we’d love a review from you. Help us reach more people to keep them in the know as we talk to leaders, high achievers, and thought leaders from diverse backgrounds and nationalities. Excellence can come from anywhere; stay in the know, and hear from emergent high achievers and gurus.

Stay updated with what’s shaping the world today through the latest The Brand Called You Podcast episode. Follow us on iTunes, Spotify, and Anchor.fm.  

You can find us at:

Website: www.tbcy.in 

Instagram: http://bit.ly/3HO7N06 

Facebook:http://bit.ly/3YzJOaD 

Twitter: http://bit.ly/3wMBOXK 

LinkedIn: https://www.linkedin.com/company/tbcy/ 

YouTube: http://bit.ly/3jmBqfq 

Chingari: https://chingari.io/tbcypodcast 

Moj:http://bit.ly/3wOrmPv 

Josh: http://bit.ly/3WWP0nB 

Thanks for listening! 

Profile

  • Dr Khurana is the Founder and CEO of Ioncure Tech Private Limited.
  • He is a researcher in the fields of artificial intelligence and epilepsy.
  • He has been recognised for his work in data privacy and ethics in the United States. 

Leave a Reply

Your email address will not be published. Required fields are marked *